The Lund Report notes that the latest OHSU statewide forecast projects a wave of COVID-19 cases in Oregon hospitals in June, although most will be incidental. Peter Graven, Ph.D., says, “In most cases, COVID is not likely to be the primary cause of the hospitalization.”

News release from MedeAnalytics highlights OHSU’s participation in 2023 HIMSS Global Conference and Exhibition in Chicago regarding clinical and operational analytics.

In an American Journal of Managed Care article, Sancy Leachman, M.D., Ph.D., says each patient needs to weigh the benefits and risks of genetic testing for melanoma and have someone who can take the time to explain everything, including insurance risks.

The Brussels Times covers study from OHSU and other institutions suggesting a drug used to treat a common skin disease could be useful in treating alcohol use disorder.

In an interview with Good Morning America, Alison Edelman, M.D., shares how ongoing legal efforts to ban Mifepristone, the most commonly used medication to end early pregnancy, have affected reproductive health providers and delivery of care: “It’s been a huge impact to have our work criminalized, basically, and not allow us to provide the care for the patient in front of us that we know is what’s best for them.”

The Lund Report covers closure of an in-house midwifery unit at McKenzie-Willamette Medical Center in Springfield, noting that OHSU is among other hospitals statewide that integrate certified nurse midwives into their labor and delivery centers.

Healio Pulmonology interviews Akram Kahn, M.D., regarding new clinical practice guidelines to manage respiratory issues in patients with neuromuscular weakness. He says, “Neuromuscular disorders are relatively rare, and an individual physician or other providers may not see many of these patients regularly. This guideline allows providers to assess their management plan against expert recommendations and best use available local resources.”

Radiology Business covers a new study led by Jeff Gold, M.D., that found shortcomings in electronic health records appear to be a contributing factor leading to diagnostic errors in radiology. He says, “These results highlight the importance of the continued work needed to optimize EHR design, interoperability, training and safety surveillance to reduce diagnostic errors.”

Charles Fennell is interviewed by KOIN regarding recruitment for a clinical trial testing a monoclonal antibody to prevent the onset of symptoms of Alzheimer’s disease, especially among people of color who are disproportionately impacted by the disease. He says, “Black people, indigenous people, people of color experience Alzheimer’s up to two times more than white people, so we’re looking for people at high risk for Alzheimer’s disease.”

Researchers have created the largest atlas of post-zygotic mutations in healthy human tissue ever assembled, in a study published in the journal Science. Senior author Don Conrad, Ph.D., says, “If you’re talking about genetic changes being the basis of disease, there are a wide variety of technologies now that allow us to make changes to the genome. It may be possible to change those mutations we’ve acquired due to bad luck or bad habits."